- Home
- WDAY vs CNC Comparison
WDAY vs CNC Comparison
Compare WDAY & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WDAY | CNC |
|---|---|---|
| Founded | 2005 | 1984 |
| Country | United States | United States |
| Employees | 21000 | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.5B | 33.5B |
| IPO Year | 2012 | 2001 |
Fundamental Metrics
Financial Performance| Metric | WDAY | CNC |
|---|---|---|
| Price | $135.34 | $63.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 34 | 16 |
| Target Price | ★ $202.50 | $46.75 |
| AVG Volume (30 Days) | ★ 3.7M | 2.9M |
| Earning Date | 05-21-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 2.03 | ★ 3.11 |
| Revenue | $2,143,050,000.00 | ★ $194,777,000,000.00 |
| Revenue This Year | $13.80 | $8.31 |
| Revenue Next Year | $11.30 | $1.05 |
| P/E Ratio | $62.99 | ★ $20.49 |
| Revenue Growth | ★ 36.55 | 19.44 |
| 52 Week Low | $110.36 | $25.08 |
| 52 Week High | $249.85 | $69.36 |
Technical Indicators
Market Signals| Indicator | WDAY | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 50.21 | 45.36 |
| Support Level | $113.15 | $63.20 |
| Resistance Level | $150.29 | $69.32 |
| Average True Range (ATR) | 7.08 | 2.24 |
| MACD | -0.95 | -0.68 |
| Stochastic Oscillator | 37.09 | 5.54 |
Price Performance
Historical ComparisonAbout WDAY Workday Inc.
Workday is a software company that offers human capital management, financial management, and business planning solutions for enterprises. Known for being a cloud-only software provider, Workday was founded in 2005 and is headquartered in Pleasanton, California.
About CNC Centene Corporation
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.